The role of heterodimerization between VEGFR-1 and VEGFR-2 in the regulation of endothelial cell homeostasis.
about
Vascular endothelial growth factor-B in physiology and diseaseCanonical and noncanonical vascular endothelial growth factor pathways: new developments in biology and signal transduction.Structural and mechanistic insights into VEGF receptor 3 ligand binding and activationCancer targeted therapeutics: From molecules to drug delivery vehicles.Attenuation of VEGFR-2 expression by sFlt-1 and low oxygen in human placentaCD146 acts as a novel receptor for netrin-1 in promoting angiogenesis and vascular development.N-terminal cleavage and release of the ectodomain of Flt1 is mediated via ADAM10 and ADAM 17 and regulated by VEGFR2 and the Flt1 intracellular domainMMP14 Cleavage of VEGFR1 in the Cornea Leads to a VEGF-Trap Antiangiogenic EffectBiophysical Studies of the Induced Dimerization of Human VEGF Receptor 1 Binding Domain by Divalent Metals Competing with VEGF-A.PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled RamucirumabPlacental hypoxia, endoplasmic reticulum stress and maternal endothelial sensitisation by sFLT1 in pre-eclampsia.Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivoDSGOST inhibits tumor growth by blocking VEGF/VEGFR2-activated angiogenesis.Angiogenesis in the atherosclerotic plaque.Vandetanib for the treatment of thyroid cancer: an update.Placental growth factor in cancer.Complications of subspecialty ophthalmic care: systemic complications from the intravitreal administration of agents that target the vascular endothelial growth factor pathway.Endothelial Cell Response to Fusobacterium nucleatumThe basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.Systematic analysis of somatic mutations driving cancer: uncovering functional protein regions in disease development.The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cellsDifferential apicobasal VEGF signaling at vascular blood-neural barriers.Restoring placental growth factor-soluble fms-like tyrosine kinase-1 balance reverses vascular hyper-reactivity and hypertension in pregnancyPathogenic CD8+ T Cells Cause Increased Levels of VEGF-A in Experimental Malaria-Associated Acute Respiratory Distress Syndrome, but Therapeutic VEGFR Inhibition Is Not Effective.VEGFB/VEGFR1-Induced Expansion of Adipose Vasculature Counteracts Obesity and Related Metabolic Complications.Placental Growth Factor is Required for Ovulation, Luteinization, and Angiogenesis in Primate Ovulatory Follicles.De novo hem- and lymphangiogenesis by endothelial progenitor and mesenchymal stem cells in immunocompetent mice.VEGF-A121a binding to Neuropilins - A concept revisited.Sustained Placental Growth Factor-2 Treatment Does Not Aggravate Advanced Atherosclerosis in Ischemic Cardiomyopathy.Proangiogenic Interactions of Vascular Endothelial MMP14 With VEGF Receptor 1 in VEGFA-Mediated Corneal Angiogenesis.Quantum dot multiplexing for the profiling of cellular receptors.Positive and Negative Regulation of Angiogenesis by Soluble Vascular Endothelial Growth Factor Receptor-1.Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2.Therapeutic Angiogenesis of Chinese Herbal Medicines in Ischemic Heart Disease: A Review.Polarised VEGFA Signalling at Vascular Blood–Neural Barriers.
P2860
Q27003400-A35952B7-209F-4896-8761-D2970F99FA17Q27342723-BBA3B0B5-B151-4EAE-88DF-9E1C900301B9Q27679183-5766C80A-BDBB-4498-9A4B-C5454FBFBA90Q33887986-E21804B1-6496-4FF5-A96C-C8EECF66CAB2Q35049491-9AE11BC5-1983-463E-995C-CC55DB460D6EQ35146217-CF38E19B-162D-4CD0-8737-9B4595EE3812Q35410651-21F0E8EF-99B2-4B23-B265-D19236BAABEBQ35979968-C278C6A8-FB8B-43E9-9993-4CCDA2DF0A99Q36220022-5069CEA4-33C9-4A0A-B841-8F79349A2AFBQ36535436-6625A38F-57E0-4A23-A799-374C68AF017DQ36770326-803DB80A-42C9-4582-A5B1-36F040782262Q37207348-CF9318D6-CE10-4552-8A3C-FB9332F07D2CQ37225399-40A7521B-E424-4E18-B3D5-DDD728F4EC18Q37645436-A3EE56AD-DE31-458B-A5FC-136B77DBCC9EQ38185691-77774373-3296-4741-90C6-B532748DA778Q38258289-AEFB6B75-DF69-44F9-9AF2-065D8212AA7EQ38261105-FB670A59-60C3-41DE-94EA-AC2FC7185E29Q38866495-A3CBB47A-BF0C-42E6-9EF8-5D83B4BFF4F9Q39131192-78AE2E5F-E8E9-493B-B5E2-ADEB4AF79942Q39790685-B68AEBC1-3446-4AFD-8414-92547B7FE2D1Q41364759-C769C2BB-F2BB-46DE-8EE8-60CB5AA896BCQ42030071-6F4616CF-F33B-4B5C-9E41-496BDD693EAFQ42356968-7996FB57-BEB5-45FC-941F-E032CBDA2137Q42369962-7EC8D0EE-80F2-40DC-ABA6-52B4A3687B33Q42491822-FF2DB1CD-E239-4F74-A0BD-76F48E56E68FQ45071708-52CCF174-7915-459D-8674-D38E67B85902Q45344058-AFF47969-EBB0-4826-BCEB-DA29C5845A3EQ47388605-32DB2502-4EBD-4595-988C-0386EF77BA69Q48293024-3F3022A7-0F10-4342-95FE-D691BE7D9D95Q50200835-0810C244-C5D0-4386-A38C-93D57DEC2D01Q51717661-D3432208-8213-4DD3-ACA4-0FFE4754FADDQ52558418-9E3EB3BB-0B8D-4172-95F0-96497BA9C429Q52717006-634D5402-FBDC-44D7-9D0C-61E56C50D3E2Q54969538-0DF75821-0CA0-4445-94DA-6E56A47C8F45Q55030483-CD078622-EFA5-4ACE-B489-B05A49B602E9
P2860
The role of heterodimerization between VEGFR-1 and VEGFR-2 in the regulation of endothelial cell homeostasis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The role of heterodimerization ...... endothelial cell homeostasis.
@en
The role of heterodimerization ...... endothelial cell homeostasis.
@nl
type
label
The role of heterodimerization ...... endothelial cell homeostasis.
@en
The role of heterodimerization ...... endothelial cell homeostasis.
@nl
prefLabel
The role of heterodimerization ...... endothelial cell homeostasis.
@en
The role of heterodimerization ...... endothelial cell homeostasis.
@nl
P2093
P356
P1476
The role of heterodimerization ...... endothelial cell homeostasis.
@en
P2093
Asif Ahmed
Bahjat Al-Ani
Bernhard Barleon
David E Newby
Herbert Weich
Ke-Qing Wang
Mark R Miller
Melissa J Cudmore
P2888
P356
10.1038/NCOMMS1977
P407
P50
P577
2012-07-24T00:00:00Z
P5875
P6179
1045362398